Cargando…
Proteases and Their Potential Role as Biomarkers and Drug Targets in Dry Eye Disease and Ocular Surface Dysfunction
Dry eye disease (DED) is a multifactorial disorder that leads to ocular discomfort, visual disturbance, and tear film instability. DED is accompanied by an increase in tear osmolarity and ocular surface inflammation. The diagnosis and treatment of DED still present significant challenges. Therefore,...
Autores principales: | Ramos-Llorca, Alba, Scarpellini, Camilla, Augustyns, Koen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456293/ https://www.ncbi.nlm.nih.gov/pubmed/36077189 http://dx.doi.org/10.3390/ijms23179795 |
Ejemplares similares
-
The Potential Role of Regulated Cell Death in Dry Eye Diseases and Ocular Surface Dysfunction
por: Scarpellini, Camilla, et al.
Publicado: (2023) -
A novel serine protease inhibitor as potential treatment for dry eye syndrome and ocular inflammation
por: Joossen, Cedric, et al.
Publicado: (2020) -
Dry Eye Management: Targeting the Ocular Surface Microenvironment
por: Zhang, Xiaobo, et al.
Publicado: (2017) -
Improved Synthesis
of the Selected Serine Protease
uPA Inhibitor UAMC-00050, a Lead Compound for the Treatment of Dry
Eye Disease
por: Ceradini, Davide, et al.
Publicado: (2022) -
Lacrimal Gland, Ocular Surface, and Dry Eye
por: Ding, Chuanqing, et al.
Publicado: (2016)